In this newly created position Mr Cearnal will be directly involved with Cumberland’s commercial strategy and business development initiatives.
During his 40-year healthcare career, Mr Cearnal has been involved with the launches of pharmaceutical products including Lipitor, Actos, Intron-A, Straterra, Botox and Humira.
Mr Cearnal began his career at Revlon Healthcare, working in a variety of domestic and international marketing positions and eventually serving as the company’s vice president of marketing for international operations. He has been a member of Cumberland’s board of directors since 2004.
AJ Kazimi, CEO of Cumberland Pharmaceuticals, said: “We are delighted to have Marty join Cumberland’s management team in this important new role. His broad knowledge of the pharmaceutical industry and considerable expertise will be a great asset to our company.”